Therefore, there is an urgent need to identify specific predictive biomarkers related to postpartum AGT among individuals with GDM, which may facilitate the application of appropriate individual lifestyle or/and pharmacological interventions to prevent or delay the progression of GDM to postpartum AGT [12,13]. The gene discussed is AGT; the disease is gestational diabetes.